Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Headline outcomes only

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Withdrawal (all‐cause) · participants with stable stage 2 and 3 COPD (mainly FEV1 49 ± 12% predicted), ex‐smokers (majority), smokers and non‐smokers

Beclometasone showed no clear difference in withdrawal (all‐cause) compared with placebo (low certainty).

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
OR 1.33 [0.83, 2.14]
2 studies · 292 participants
Low

Withdrawal (all‐cause) · participants with stable stage 3 COPD, smokers and ex‐smokers with a minimum pack‐year history of 20

Beclometasone/LABA showed no clear difference in withdrawal (all‐cause) compared with LABA (moderate certainty).

1 finding from 1 review

Beclometasone for chronic obstructive pulmonary disease 2013 · Cochrane Headline outcomes only
OR 0.91 [0.54, 1.53]
1 study · 474 participants
Moderate